Purpose: To examine and facilitate the feasibility of the ArcCheck cylindrical diode array system as a patient specific QA device for CyberKnife radiosurgery delivery. Methods: There is an obvious necessity for CyberKnife robotic radiosurgery patient QA procedures for hypofractionated treatment of larger planned treatment volumes (PTV), e.g. prostate. This need will increase when the future CyberKnife MLC is introduced. The small unflattened CyberKnife fields, along with the variation of beam‐to‐detector spatial angles, pose a significant detection challenge for dosimetric systems. The feasibility of the ArcCheck (Sun Nuclear Inc.) cylindrical diode array system for patient‐specific QA on the CyberKnife is demonstrated using a beam‐to‐diode specific angular correction that was developed and has been applied. For localization and tracking, four gold seed fiducial markers were embedded in the system's central plug. We used a Monte Carlo 1% uncertainty for the dose calculation. Results: By disabling the Linac based corrections and applying the custom CyberKnife correction that we developed, the passing rate increased from 39.6% to 99.8% using a 3%3mm gamma criteria for a given lung case. An additional lung case passed 98.5%. In both cases, a 10% dose threshold was used. In addition, brain, trigeminal nerve and lung cases with synchrony tracking are being investigated. Conclusions: We demonstrated the ArcCheck feasibility for CyberKnife patient specific QA performance. The custom CK angular correction that we developed and applied showed a high passing rate for the lung cases. A verification of the polar angle response should be conducted, in addition to the azimuthal angle that was verified for Linacs. Any data that is being retrieved is additional data to the current chamber point measurement procedures.